Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2016

Jun 29, 2016

30826_dirs_2016-06-29_e79e380a-f2e7-4bba-82b5-0a9fd7b52d9e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2016-06-28

Reporting Person: RYAN THOMAS F JR (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-06-28 Common Stock M 5000 $3.22 Acquired 27094 Direct
2016-06-28 Common Stock S 10000 $24.5888 Disposed 17094 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-06-28 Stock Option (Right to Buy) $3.22 M 5000 Disposed 2021-12-15 Common Stock (5000) Direct

Footnotes

F1: $24.5888 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.4601 to $24.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.